One of the dangers of transvaginal mesh devices, according to an article in The Trial Lawyer magazine, is that they typically can’t be removed once they’ve been implanted in a patient’s body.
This is bad news for the thousands of implant recipients who have reported problems including debilitating pain and organ perforation after the devices have started to erode. According to The Trial Lawyer, doctors can trim ...
continue reading...
A newspaper report warns New Zealanders to brace for another round of invasive surgery after a recall of more hip implants.
According to The Dominion Post, Smith & Nephew R3 hip implants were recalled after unusually high rates of replacement surgery were required in Australia and the United Kingdom.
The report mentions a similar recall of DePuy all-metal hip implants from 2010. ...
continue reading...The U.S. Food and Drug Administration has reviewed Novartis AG’s multiple sclerosis drug Gilenya, and concluded that patients who’ve suffered a heart attack or stroke within the past six months shouldn’t take it.
The review came about after a 59-year-old patient died in November, less than 24 hours after taking the first dose of the drug.
Europe’s drug regulator, the European Medicines Agency, recently requested stronger safety warnings for Gilenya after the agency concluded its review of the drug.
According to Dow Jones ...
continue reading...A story in the Spring, 2012, issue of The Trial Lawyer magazine takes a look at the flaws in the federal approval process that allow dangerous transvaginal mesh kits to be implanted in women, with disastrous results.
The article is called “Transvaginal Pelvic Organ Prolapse Kits: The Chronicle of Failure.” It describes a system in which representatives of medical device companies frequent the offices of OB/GYNs and surgeons, urging them to ...
continue reading...
